774
S U B J E C T I N D E X
Proline—continued
hydroxylation of, 305-7, 690
inessential for bone cells, 163
inhibitory to heart tissue, 299
precursors of, 2 8 7 - 9
produced from glucose, 115, 250, 299
site o f incorporation of, 306-7
utilization b y bone rudiments, 304
Prometaphase, 205, 211
Pronephros,
induced b y bone marrow, 546
Prophase, 205
D N A in, 209, 322
duration of, 421
meiotic, 208, 439
nucleolus and, 217
R N A in, 207
spindle in, 211
Prosencephalon,
iodoacetate and, 571
Prospective fates,
of anlage, 538-9
Prostate,
amino acids and, 128, 304
arginase activity in, 3 0 4 - 5 , 308
culture of, 71, 84, 128
male hormone and, 633
oxygen requirement of, 77
survival time of, 83
testis and development of, 617-18
tumours of, 628, 630-1
ventral, and hormones, 6 2 1 - 4 , 628-32
vitamin A and, 660-1
Prosthetic groups,
polysaccharides as, 355
Protease (see also Proteolytic enzymes),
and breakdown o f matrix, 381
hydrocortisone and, 615
inhibitor, 310-11
in monocytes, 310
released from lysosomes, 611, 615
synthesis of, 677
vitamin A and, 309-10, 4 7 1 , 6 1 5 , 6 7 6 - 7
Protein,
anaerobic synthesis of, 251
breakdown, 302, 309-10
in cartilage matrix, 381
and cell nutrition, 278, 310
and cell surface, 104, 108, 158
content o f primary cultures, 306
content o f single cells, 331
and differentiation, 568-70
and glass surfaces, 104, 2 9 1 - 2
from glutamine, 287
hydrolysates of, 105
as inducing agents, 543, 549, 551-3
insulin and synthesis of, 593
measurement o f radioactive, 307
metabolism and differentiation, 297
production b y cells, 104
requirement for, 103-5, 2 9 1 - 2
and suspension cultures, 292
turnover, 2 4 1 - 2 , 293, 309, 331
Protein synthesis, 290, 321
extracellular, 241
and growth hormone, 601
induced and repressed, 307-8
inhibition of, 223, 343, 501
in macrophages, 309
as measure o f growth, 247
and nucleic acids, 330, 332-4, 336
and reaggregation, 521
Proteolytic enzymes (see also Proteases),
and dissociation o f cells, 54
in embryo juice, 310
and function o f antra in thyroid, 602
and inactivation o f inducers, 552
and invasiveness o f tumours, 383
and iodide, 603
in lysosomes, 309, 381, 611, 679
vitamin A and, 677
Proteose,
utilization of, 310
Pseudopodia,
o f astrocytes, 40
and cell attachment, 520
in fluid medium, 178
lobose, o f amoebocytes, 162
of lymphocytes, 148, 179
of macrophages, 146, 179
of mechanocytes, 162, 178
mutual suppression of, 184-5
of oligodendrocytes, 148
orientation of, 183-4
of polymorphs, 179
size of, and speed o f movement, 183
Pseudoprophase, 207-8
Puck's solution, 131
Pulsation,
of simple heart cells, 475
Pulse labeling,
method of, 419, 438, 440
Pulvertaft chamber, 39
S U B J E C T I N D E X
Proline—continued
hydroxylation of, 305-7, 690
inessential for bone cells, 163
inhibitory to heart tissue, 299
precursors of, 2 8 7 - 9
produced from glucose, 115, 250, 299
site o f incorporation of, 306-7
utilization b y bone rudiments, 304
Prometaphase, 205, 211
Pronephros,
induced b y bone marrow, 546
Prophase, 205
D N A in, 209, 322
duration of, 421
meiotic, 208, 439
nucleolus and, 217
R N A in, 207
spindle in, 211
Prosencephalon,
iodoacetate and, 571
Prospective fates,
of anlage, 538-9
Prostate,
amino acids and, 128, 304
arginase activity in, 3 0 4 - 5 , 308
culture of, 71, 84, 128
male hormone and, 633
oxygen requirement of, 77
survival time of, 83
testis and development of, 617-18
tumours of, 628, 630-1
ventral, and hormones, 6 2 1 - 4 , 628-32
vitamin A and, 660-1
Prosthetic groups,
polysaccharides as, 355
Protease (see also Proteolytic enzymes),
and breakdown o f matrix, 381
hydrocortisone and, 615
inhibitor, 310-11
in monocytes, 310
released from lysosomes, 611, 615
synthesis of, 677
vitamin A and, 309-10, 4 7 1 , 6 1 5 , 6 7 6 - 7
Protein,
anaerobic synthesis of, 251
breakdown, 302, 309-10
in cartilage matrix, 381
and cell nutrition, 278, 310
and cell surface, 104, 108, 158
content o f primary cultures, 306
content o f single cells, 331
and differentiation, 568-70
and glass surfaces, 104, 2 9 1 - 2
from glutamine, 287
hydrolysates of, 105
as inducing agents, 543, 549, 551-3
insulin and synthesis of, 593
measurement o f radioactive, 307
metabolism and differentiation, 297
production b y cells, 104
requirement for, 103-5, 2 9 1 - 2
and suspension cultures, 292
turnover, 2 4 1 - 2 , 293, 309, 331
Protein synthesis, 290, 321
extracellular, 241
and growth hormone, 601
induced and repressed, 307-8
inhibition of, 223, 343, 501
in macrophages, 309
as measure o f growth, 247
and nucleic acids, 330, 332-4, 336
and reaggregation, 521
Proteolytic enzymes (see also Proteases),
and dissociation o f cells, 54
in embryo juice, 310
and function o f antra in thyroid, 602
and inactivation o f inducers, 552
and invasiveness o f tumours, 383
and iodide, 603
in lysosomes, 309, 381, 611, 679
vitamin A and, 677
Proteose,
utilization of, 310
Pseudopodia,
o f astrocytes, 40
and cell attachment, 520
in fluid medium, 178
lobose, o f amoebocytes, 162
of lymphocytes, 148, 179
of macrophages, 146, 179
of mechanocytes, 162, 178
mutual suppression of, 184-5
of oligodendrocytes, 148
orientation of, 183-4
of polymorphs, 179
size of, and speed o f movement, 183
Pseudoprophase, 207-8
Puck's solution, 131
Pulsation,
of simple heart cells, 475
Pulse labeling,
method of, 419, 438, 440
Pulvertaft chamber, 39